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PENETRATION OF SPINALLY ADMINISTERED 
OPIOIDS INTO THE LUMBAR SPINAL CORD OF CATS: 
AN AUTORADIOGRAPHIC STUDY. 
Joe Wayne Kurosu 
1986 
Although the analgesic action of opioids has, in 
the past, been attributed to supraspinal sites of action, 
evidence has now accumulated indicating direct actions 
at the spinal cord level. Animal and human studies 
have shown that spinally administered opioids can produce 
a powerful segmental analgesia without loss of other 
sensory or motor functions. The exact mechanisms by 
which spinally administered opioids give rise to this 
analgesia, however, are not entirely clear. This study 
was undertaken to develop an autoradiographic technigue 
suitable for investigating the penetration of spinally 
administered morphine into the lumbar spinal cord of 
cats, and, by comparing the temporal changes in radio- 
labelled morphine localization with known electrophysio- 
logical effects of spinal morphine, gain a clearer un¬ 
derstanding of the mechanisms behind spinal opioid analgesia 
Following lumbar laminectomy on six cats of either sex, 
the dura mater was reflected, exposing the spinal cord. 
The cerebrospinal fluid was then suctioned off and replaced 
with a solution of -^H-morphine (25 uCi in 25 ul ) and 
unlabelled morphine sulfate (0.25 mg in 0.5 cc] in a 
total volume of 525 ul. After 30 seconds, 5 minutes, 
or 10 minutes, the lumbar spinal cord was rapidly removed, 
cut into 5 segments each about E mm thick and numbered 
1-5 from rostral to caudal then immediately frozen in 
isopentane cooled to -65°C with dry ice. Sections (8 
microns thick) of the frozen tissue were obtained in 
a cryostat at -15 °C, placed on gelatin coated slides, 
and freeze-dried at - 15 JC under vacuum in a dessicator. 
Slides were then dipped into a liguid emulsion diluted 
1:E with double distilled deionized water and exposed 
for four weeks in light-tight boxes at -15 °C. The autoradio 
graphs were then developed , stained with 2.5% cresyl 
violet, and examined under a light microscope. Autoradio¬ 
graphic grain density per 625 u^ was obtained in selected 
areas (posterior column, laminae I, II, V, VII, and 
ventral horn) by visual counting. The technigue used 
produced autoradiographs of good histological guality 
with uniformly low levels of radiographic background. 
Analysis of data by rostra1-cauda1 segments did not 
reveal any consistent trends in grain distribution. 
CZ\ 
111. 
Data pooled without regard to segment number was thus 
analyzed, and showed that grains were present in amounts 
greater than background within 30 seconds after morphine 
application in all areas sampled. Furthermore, there 
was a significant increase (F.01 by t-test for unpaired 
data] in grain density in all areas sampled between 
the 5-minute and 10-minute time intervals. The variability 
in grain counts, however, was felt to be relatively 
large. Thus, it was concluded that the autoradiographic 
technigue used was satisfactory for the study of penetration 
of opioid compounds into the spinal cord, although the 
somewhat large variability in grain counts suggested 
that some movement of radioactive morphine was occuring 
during the tissue processing. Also, morphine, despite 
its low 1ipophi1icity, was shown to penetrate to the 
deeper laminae of the spinal cord within minutes after 
application , but the study did not allow any conclusions 
to be drawn on the specific binding or action of the 
drug at these laminae. Finally, the temporal changes 
in autoradiographic grain density were concluded to be 
consistent with the known time course of suppression 
of dorsal horn WDR neurons by spinally applied morphine. 

ACKNOWLEDGEMENTS 
First and foremost, I would like to acknowledge the 
efforts of Professor Luke M. Kitahata for allowing me 
to utilize his resources and for his time, advice, patience 
and understanding in all aspects of this thesis project. 
In addition, I would like to thank Dr. Raymond S. Sinatra 
and Or. Jerry G. Collins for their kind assistance, 
advice, and direction throughout all stages of this 
study. I am most indebted to my mentors in the laboratory, 
□rs. M. Aoki, Y. Kumeta, K. Murata, and Y. Nishio for 
their unlimited patience in helping me with the often 
time consuming "drudgery” of daily lab work. No part 
of this project would have been possible without their 
assistance. Finally, I would like to dedicate this 
thesis to my parents, Or. S Mrs. Yoshio Kurosu, for 
whom words cannot adeguately express my sense of respect, 
appreciation, and love. 

T T Now Helen, the daughter of Zeus, turned her thoughts 
elsewhere. Straightway, she cast into the wine of 
which they drank, a drug which quenches pain and strife 
and brings forgetfulness to every ill." 




Opium has been known to man for at least 6000 
years (59)„ Although it is likely to have been used 
for its psychological effects, specific medical 
were eventually developed (21), and many 
of the current uses of opioids were established by 
three or four hundred years ago (25). Insights into 
the mechanisms by which opium exerted its various effects, 
however, came somewhat more slowly. For example, morphine, 
the principle alkaloid contained in opium, was not 
isolated until the early 19th century (59), and it 
was not until much more recently that specific receptors 
for opioids were shown to exist in animal tissue (25)„ 
Furthermore, although it has been suspected for some 
time that opium and its derivatives acted predominantly 
on the nervous system (59), more precise localization of 
the sites of action of opioids has come only within 
the past ten to twenty years. Earlier studies concentrated 
on supraspinal areas as potential sites of action of 
opioids, but with the demonstration of opiate receptors 
in the spinal cord, discovery of the endogenous opioids, 
and evidence that opioids have direct effects on the 
spinal cord (38), it became apparent that opioids may 
exert their effects both at the spinal and supraspinal 

levels. As Yaksh has painted out (76), this discovery 
of the spinal action of opioids proved to be of ’’signi¬ 
ficant clinical importance,” and clinical use and investi¬ 
gations of intrathecal or epidural opioids has become 
increasingly common (9), Many questions, however, 
still remain. One of these concerns the exact site 
of action of spinally administered opioids. There 
already exists some evidence painting to specific areas 
of the spinal cord as sites where opioids may be exerting 
their effects (76). The present study aims to provide 
further evidence by investigating the time course of 
penetration of spinally administered morphine into 
the spinal cord and correlating these results with 
the known e1ectrophysio1ogica1 responses of spinal 
cord neurons to morphine applied spinally. 
Before detailed discussion of the present study, 
it is felt that a review of some background material 
would be appropriate. In the introduction which fallows, 
a brief history of opioids and their medical uses will 
be given, followed by a discussion of the concept of 
opiate receptors, theories on sites of opioid action, 
and, finally, a discussion of the proposed sites of 
action of spinally administered opioids. A brief dis¬ 
cussion of the technique of autoradiography will also 
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be made. Research related to opioids has mushroomed 
in the past 10 to 15 years. The following discussion 
is thus in no way meant to be a comprehensive one but 
will serve as a background for the present study. 

4 
HISTORY OF OPIUM AND ITS MEDICAL USES 
Crude opium is the white sap which exudes when 
the unripe seed capsules of the poppy plant (Papaver 
somniferum) is scratched. The term "opium" is the 
diminutive of the Greek "opos" which means sap (59) . 
Opium itself contains over twenty distinct alkaloids 
including morphine, codeine, thebaine, papaverine, 
and noscapine (25). Curiously enough, this white sap 
is present in the plant for only ten days, after which 
it is broken down (59). Perhaps even more intriguing 
is why the plant produces this substance in the first 
place. The reason for this is not clear. We do know 
however, that opium "has affected the history of the 
human race, causing wars, threatening society, and 
bringing comfort to those in pain (59) . T? 
As mentioned above, opium has been known to man 
for quite some time. The poppy is referred to as a 
’’plant of joy” in Sumerian ideograms dating back to 
4000 B.C. (21), and seeds of the cultivated poppy have 
been found in relics of Stone Age lake dwellers in 
Switzerland (59). The first known to opium 
as a medicine can be found in the Therapeutic Papyrus 
of Thebes from Egypt in 1552 B.C., which describes 
a mixture of fly excretions and opium prescribed for 
quieting crying babies (21). From Egypt, the poppy 
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Found its way to Greece, Hippocrates (460-357 B.C,) 
seems to have been wary of the eFFects oF opium, and 
although his Egyptian counterparts were prescribing 
the use oF opium Freely by this time, he was against 
the liberal use oF such drugs (21). Dioscorides, another 
Greek physician, used opium not only as a soporiFic 
and analgesic, but also to treat such conditions as 
chronic cough (59). 
The Romans used opium in increasing amounts, perhaps 
in part due to Galen (130-201 A.D„) who Felt that it 
cured, among other things, "deaFness, epilepsy, asthma, 
jaundice, Fevers, melancholy, and all pestilences (59).” 
The Arabs are generally credited with spreading the 
use oF opium both eastward and westward. Thus it was 
through them that during the sixth century opium was 
introduced into India, and From there into China. 
The image oF opium in China is one oF opium smoking 
addicts, but it was not until the 17th century when 
tobacco was prohibited that this mode oF taking opium 
became popular in that country. Prior to this, opium 
was used as a medicine by only a select class o F Chinese 
(59) . 
Meanwhile in Europe, opium continued to enjoy 

G 
great popularity. Paracelsus, a Swiss doctor of the 
early 16th century thought to be an opium addict himself, 
played an important role in popularizing the use of 
opium in Europe. He claimed that he possessed "a secret 
remedy. . .[called] laudanum. . .which is superior to all 
heroic remedies (25] ." 
after whom the "sylvian fissure" is named, once reported 
that he would not want to practice medicine without 
opium (21]. Thomas Sydenham of England went so far 
as to say that "without opium the healing arts would 
cease to exist (59]." 
As widespread use of opium continued, the search 
was beginning for the "basic principle" or "quintessence" 
of opium in hopes of procuring a more powerful form 
of the drug. Various extracts and preparations were 
concocted in this search without much success until 
the early 19th century. In 1803 Oerosne, a French 
chemist, isolated a crysta11izab1e salt from opium 
which he found to be more powerful than any other extract 
and called it Sel narcotigue de Oerosne (21]. This 
salt was one of the alkaloids of opium, now known as 
narcotine or noscapine. Around the same time, a German 
named Friedrich Serturner had isolated an "element" 
from opium—a substance several times more powerful 
than crude opium—and named it morphium after Morpheus, 
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the Greek God of Sleep (25). Thus morphine had been 
isolated, and the isolation of other alkaloids from 
opium soon followed. As a result, use of the pure 
alkaloid forms rather than opium became popular in 
the medical world (25). 
The next significant development came in 1853 
when the hypodermic needle was perfected by Alexander 
Wood. This, of course, allowed for parenteral use 
of drugs, and morphine was no exception as its medical 
use by hypodermic injection was pioneered in the U.S. 
by Fordyce Barker and George T. Elliot (59). 
Since that time, a variety of natural, synthetic, 
and semi-synthetic opioid drugs have come into use. 
In addition to their parenteral and oral use as analgesics, 
they have come to be employed in moderate doses as 
adjuncts to general anesthesia, in high doses as anesthetic 
for cardiac surgery, and most recently via the subarach¬ 
noid or epidural route for pain 
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THE OPIATE RECEPTOR 
Despite such a long relationship between man and 
opiates, detailed knowledge of the sites and modes 
of action of opiates has only begun to emerge recently. 
The principle site of action of opiates has long been 
thought to reside in the central nervous system, but 
further localization proved to be difficult until a 
major advance toward understanding of opiate action 
came in the early 1970’s with the identification of 
the opiate receptor. The pharmacologica1 action of 
most drugs assumes "that the initial process in drug 
action is the formation of a reversible complex between 
the drug and a cell component generally known as the 
drug receptor (5]The highly selective effects which 
opiates produce at low concentrations suggests that 
this is also true for the opiates. Three lines of 
evidence lend further support to the concept of an 
opiate receptor (61): 
1. Structure . All opiates have basic similarities 
in their molecular structure. Namely, the presence 
of a positively charged tertiary nitrogen, a flat 
phenolic base, and a hydroxyl group. 
2. Stereospecificity. Although most opiates exist 
as at least two optical isomers, only the levorotatory 
forms give rise to the selective effects of opiates. 
3. Antagonists. Minor molecular modifications of opiate 
agonists can give rise to antagonists, which block 




Thus, investigators felt quite sure that sf 
opiate receptors existed, but initial studies aimed 
at localizing the receptor met with a major obstacle— 
the fact that nonspecific binding greatly exceeded 
specific receptor binding. That is, opiates, like 
many other compounds, bind in a nonspecific fashion 
to nearly any biological membrane, and do so to such 
an extent that the small portion which is s| 
bound is difficult to detect. 
Goldstein and his colleagues were the first to 
attempt to distinguish between specific and nonspecific 
opiate binding (22). This was accomplished by using 
the criteria of stereospecificity. Homogenized brain 
3 
tissue from mice was incubated with H-1evorphano1 
in the presence of a pharmacologically active isomer 
(levorphano1) and an inactive isomer (dextrorphan). 
Figure 1 diagrams the conditions used by Goldstein 
and shows the three types of binding which he described: 
nonsaturable (trapped and dissolved), nonspecific saturable, 
and specific saturable. Trapped and dissolved opiates 
(C in fig.l) accounted for nearly 50% of the total 
binding while nonspecific saturable binding (A minus 
B in fig.l) was responsible for close to another 50%, 
leaving only 2% of total binding as that due to stereo- 
c binding (B minus C in fig.l). 
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This result was somewhat discouraging for it indi¬ 
cated that it would be a difficult task indeed to isolate 
specific binding to the putative receptor in the presence 
of large amounts of nonspecific binding. Thus, methods 
were sought which would somehow "amplify" the specific 
binding relative to the nonspecific binding, making 
it easier to detect. 
Pert and Snyder (54] were among the first to 
overcome this difficulty and demonstrate the existence 
of an opiate receptor in nervous tissue. They used 
low concentrations of an opiate antagonist with high 
- 9 3 
specific activity (5 X 10 M of H-naloxone) and washed 
the tissues rapidly with cold buffer after incubation. 
The use of small amounts of a high affinity drug favored 
specific binding, and the rapid washing helped to remove 
nonspecifically bound molecules. Samples were also 
incubated in the presence of dextrorphan and in the 
presence of levorphano1 to "subtract" out any nonspecific 
binding which remained after the washing, similar to 
Goldstein’s technique above. Using this method, they 
demonstrated highly stereospecific binding of low concen¬ 
trations of opiates, with the degree of binding paralleling 
the known pharmacological potencies of opiate agonists 
and antagonists—strong evidence for the presence of 

an opiate receptor. 
Terenius (65) independently demonstrated high- 
affinity stereospecific binding in synaptic plasma 
membrane fractions of rat cerebral cortex, using a 
technique similar to Pert and Snyder’s above, with 
3 
H-dihydromorphine. Simon et al. (60) provided further 
evidence for the existence of opiate receptors in rat 
brain homogenate using, again, a similar technique 
and the potent agonist etorphine. 
It should be noted that stereospecific binding, 
while highly suggestive, does not by itself constitute 
proof for the existence of a receptor (80). Stereospe¬ 
cific binding of opiates has, in fact, been demonstrated 
to cerebrosides (46) and even certain glass filters 
(62). Thus it was essential to demonstrate a correlation 
between the binding affinity and pharmacological activity 
for various opiates. Such a correlation was shown 
by Pert and Snyder (see above) and, perhaps more convin¬ 
cingly, by Creese and Snyder (13) who demonstrated 
an association between binding and pharmacological 
activity within the same system--the guinea-pig ileum. 
These investigators compared the ability of various 
opiates to inhibit electrically induced muscular contrac¬ 
tions with their ability to inhibit naloxone binding, 

both in the guinea-pig ileum. They were able to demonstrate 
a strong correlation between binding and pharmaco1ogica1 
action. This provided definitive evidence that the 
stereospecific binding site previously described were, 
in fact, opiate receptors. 
DISTRIBUTION OF THE OPIATE RECEPTOR 
The existence of opiate recptors was thus established, 
while nearly simultaneously, work was under way to 
examine the regional distribution of opiate receptors 
within the nervous system. In their initial study 
describing the opiate receptor, Pert and Snyder also 
examined the regoinal distribution of these receptors (54). 
In rats, they found the highest amount of binding in 
the corpus striatum, while the midbrain and cortex 
had only one-fourth this amount of binding. A more 
3 
detailed study was then done using H-diprenorphine 
in monkey and human brains (40). This study revealed 
high levels of binding in the amygdala, periaqueductal 
area of the midbrain, hypothalamus, and medial thalamus, 
while levels of binding in white matter areas was low 
or undetectable. Another study, using homogenates 
3 
of human brain and H-etorphine, found similar results 
with the highest degree of binding in components of 
the limbic system (31). 
a'. 
1 3 
All of these initial studies utilized regional 
dissection of tissues followed by homogenization as 
a means of investigating the distribution of 
and were thus limited in their degrees of anatomical 
resolution attainable. Therefore, i turned 
to microscopic technigues involving autoradiography 
in order to gain more precisian in mapping out the 
opiate receptors . 
Pert et al. (52, 53) investigated opiate receptor 
distribution in rats using light microscopic autoradio¬ 
graphy . Brain and spinal cord tissue was extracted 
3 
one hour following intravenous injection of H-diprenorphine, 
and autoradiographs were prepared using a technique 
which minimized translocation of the radioactive ligand 
during preparation of the radiographs. The autoradiographs 
revealed areas of high grain density restricted to 
relatively small areas, including the caudate-putamen, 
locus coeruleus, and the substantia gelatinosa of the 
spina1 cord. 
Similar results were found in a detailed study 
of the spinal cord and medulla of rats by Atweh and 
3 3 
Kuhar (1), using H-diprenorphine and H-etorphine. 
In addition to laminae I and II of the spinal cord, 
the autoradiographs showed high grain densities in 
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the substantia gelatinosa of the spinal trigeminal 
nucleus, components of the vagal system, and the area 
postrema. 
These studies made it apparent that opiate receptors 
were distributed in areas thought to be important in 
relaying, processing, or modulating nociceptive infor¬ 
mation, and in other areas which may be involved in 
mediating known non-ana 1gesic effects of opiates: e.g., 
area postrema — nausea/vomiting, solitary nuclei—depression 
of cough reflex, and limbic system—euphoria. 
In examining such "maps” of opiate receptors, 
it was also noted that the receptors were distributed 
in a manner closely associated with the pa1eospinotha1amic 
pain pathway [61). The pa 1eospinotha1amic pathway 
ascends along the midline of the brain, passing through 
the periagueducta1 grey, medial thalamus, and parts 
of the limbic system, and projects diffusely onto large 
areas of the cortex. This system is thought to be 
involved in the transmission of dull, poorly localized 
pain. This is in contrast to the neospinotha1amic 
pain pathway, which is more laterally located, and 
projects to the somatasensory cortex via the ventral 
nuclei in the thalamus. This system 
is thought to have evolved later, and is involved in 
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the transmission of sharp, localized pain. 
This close association of opiate receptors with 
the pa 1eospinotha1amic systems helps explain the clinical 
characteristics of opiate analgesia. That is, the 
effective control of dull, poorly localized pain and 
a modulation of the "emotional component" of pain (through 
effects on the limbic system), and relatively poor control 
sharp, localized pain. 
It should be mentioned briefly that attempts have 
been made to carry the localization of opiate receptors 
one step further and determine whether they are located 
pre- or post-synaptica11y with respect to the primary 
afferent fibers in the spinal cord. Evidence exists 
for both a pre- and post-synaptic location of opiate 
receptors (76, 77). A study by LaMotte and co-workers 
(42) showed a significant reduction in stereospecific 
opiate binding in the dorsal horn of the spinal cord 
of monkeys fallowing rhizotomies, suggesting a pre- 
synaptic location of the opiate receptors. The reduction 
in binding was, nonetheless, subtotal, implying that 
a portion of the receptors may exist post-synaptica11y. 
Although this area remains somewhat unclear, it appears 
likely that pre- and post-synaptic receptors exist, 
and that both sites can be acted upon by exogenously 
o f 
applied opiates to suppress nociceptive messages. 
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THE ENDOGENOUS OPIOIDS 
Even as the distribution of opiate was 
tissues which interacted with of the poppy 
plant. The existence of these receptors suggested 
the presence of a natural, endogenous "morphine-like" 
substance, and, as expected, a search led to the discovery 
of such a substance„ 
and Wahlstrom (66) found a purified extract 
from rat brain which was capable of inhibiting the 
binding of dihydromorphine to receptors. The solubility 
characteristics of this extract were suggestive of 
the presence of an oligopeptide. 
Hughes (34) had independently isolated a low molecular 
weight morphine-1ike substance from rabbit, guinea- 
pig, rat, and pig brain which inhibited electrically 
evoked contractions in the mouse vas deferens and guinea- 
pig ileum (like the guinea-pig ileum, the mouse vas 
deferens contains stereospecific opiate receptors which 
mediate neurally evoked contractions). This inhibition 
was reversed with naloxone. Hughes named this substance 
naloxone-reversible-activity (NRA), and suggested that 
it was a peptide or peptide containing molecule of 
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molecular weight less than 700. Pasternak [51) had 
also isolated a similar morphine-1ike factor (MLF) 
from calf and rat brain. 
Hughes went on to identify NRA from pig brain 
and found that it was composed of two pentapeptides, 
which he called methionine-enkephalin and leucine- 
enkephalin (35) [enkephalin = Gk. "in the head"]. 
Earlier in the same year, Goldstein and his colleagues 
had isolated a morphine-1ike substance from bovine 
pituitary glands [12,67) which was apparently distinct 
from the enkephalins described by Hughes. In addition, 
Hughes had noticed the peculiar fact that the sequence 
of methionine-enkephalin was identical to that of residues 
61-65 of b-1ipotropin, a 99 amino acid pituitary peptide 
involved in fat breakdown (35). Li, who had isolated 
b-1ipotropin, had also isolated a 31 amino acid fragment 
of b-lipotropin from camel pituitary whose function 
was unclear (44). Putting all of this together, investi¬ 
gators (11,45) were able to show that this 31 amino 
acid fragment of b-lipotropin from the pituitary had 
potent opioid activity, and named it b-endorphin (from 
ENGogenous mORPHINE). This accounted for only part 
of the opioid activity in Goldstein’s pituitary extract. 
Another distinct component was found in the extracts 

with patent opioid activity and named dynorphin (23)„ 
Thereafter, a variety of other peptides with opioid 
activity were isolated from pituitary and brain tissue (10). 
or its fragments might have served as precursors to 
enkephalin, this is now thought not to be the case 
(see 63) . In fact, the endogenous opioid peptides 
have now been separated into three general classes, 







□ YNORPHI NS---PREPRODYNORPHIN 
The exact functions of each of these endogenous 
opioids are not entirely clear. The regional distribution 
of enkephalins closely parallels that of opiate receptors, 
and they are apparently localized in nerve endings, 
suggesting that they may be neurotransmitters involved 
in mediating sensory information concerned with pain 
and emotional behvior. Enkephalins have also been 
found in the small intestine of a number of species 
indicating a possible role in gastrointestinal motility 
(25). B-endorphin is found predominantly in the posterior 
pituitary and hypothalamus, and is bsent 
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in the remainder of the brain (63). Thus, it has been 
suggested that b-endorhin may play a role in modulating 
pituitary activity, such as release of 
hormone (63), and that its analgesic action may be 
unrelated to its normal physiological function (61). 
There is evidence, however, that b-endorphin may be 
involved in pain modulation (33). The function of 
the dynorphins is even less well understood. 
Although the details of their respective functions 
remains to be determined, methionine-enkepha1in, leucine- 
enkephalin, and dynorphin have been found in the dorsal 




As these various endogenous opioid compounds were 
that there may actually be more than one type of opiate 
receptor . Martin (48) described three distinct beha¬ 
vioral syndromes produced by various opiate agonists 
in chronic spinal dogs, and attributed each of these 
to effects at separate opiate receptor subtypes, which 
he named mu (u), kappa (k), and sigma(o). Since this 
study, other opiate receptor subtypes have 
been described, including delta (d) and epsilon (e) 
(47,74) 
SUBTYPES WITHIN THE SPINAL CORD 
A detailed description of all the subtypes, their 
distribution, and the effects which they mediate is 
beyond the scope of this discussion. It should be 
mentioned, however, that within the spinal cord, the 
presence of u-, k-, and d- receptors has been described 
(19,24,70,71). Although the relative importance of 
these receptors in nociception is not clear, a study 
by Schmauss and Yaksh (58) has provided evidence that 
these receptor subtypes may be involved in modulating 
different types of nociceptive stimuli. They found 
that in rats, intrathecal administration of mu and 
delta, but not kappa, agonists inhibited responses 
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to cutaneous thermal stimuli, while mu and kappa, but 
not delta, agonists inhibited responses to visceral 
chemical stimuli. This is part of the evidence available 
which suggests that there may be distinct endogenous 
opioid systems at the spinal cord level which subserve 
the processing oh different types of nociceptive input. 
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SITES OF OPIOID ACTION 
The sites and modes of action of opioids has been 
an area of much speculation for many years. The identification 
of the opiate receptor and discovery of the endogenous 
opioid peptides has helped immensely in the understanding 
of this area, although in some ways (e.g., the concept 
of multiple opiate receptor subtypes) it seems to have 
added complexity to an already confusing field. 
One area in which a significant amount of knowledge 
has been gained is that of opioids and their effects 
within the spinal cord. As may be expected, the literature 
on this subject is already guite voluminous; an attempt 
will be made here to review only those investigations 
felt to be most relevant to the present study. 
SPINAL VS. SUPRASPINAL ACTION OF OPIOIDS 
There has been, and perhaps still is, some controversy 
regarding the effects of opioids at the spinal level. 
In many cases, earlier investigators favored the view 
that systemically administered opioids activated descending 
pathways supraspinally which then inhibited transmission 
of nociceptive information at the spinal level, rather 
than a direct effect at that level. 
Basbuam and Fields (2,IQ) described a brainstem analgesic 
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system involving the nucleus raphe magnus in the medulla, 
and speculated that projections from this supraspinal 
site to the spinal cord were essential to "opiate-produced 
ana 1gesia." 
A study by Satoh and Takagi [57) showed that intravenous 
morphine decreased the amplitude of evoked potentials 
recorded from the ventrolateral fasciculus of the spinal 
cord following stimulation of the splanchnic nerve 
in pentobarbita1-anesthetized cats. This decrease 
in amplitude was reversed when the spinal cord was 
blocked at the C-1 level, leading the investigators 
to conclude that the observed effect was due to an 
increased descending inhibition of spinal sensory trans¬ 
mission. Duggan has pointed out, however, that tonic 
descending inhibition may be present in barbiturate- 
anesthetized cats, making the results of Satoh's study 
difficult to interpret (16). Nevertheless, other investi¬ 
gators also felt that the evidence available at the 
time supported "activation of a descending inhibitory 
system” as the mechanism responsible for opioid analgesic 
action (28,50). 
Other studies, however, were beginning to show 
that opioids may have a direct effect at the spinal 
cord level, independent of its effects at supraspinal 
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sites. Evidence that opioids may have significant 
effects at the spinal cord level was, in fact, presented 
over forty years ago by Wikler (73]. Using acute and 
chronic spinal cat preparations, Wikler found that 
intravenous morphine (2-15 mg/kg) markedly depressed 
responses to nociceptive stimuli (flexor and crossed 
extensor reflexes] while responses to stretch (knee 
and ankle jerks] were unchanged or slightly enhanced. 
This suggested the possibility that morphine was having 
a direct effect upon interneurons within the spinal 
cord . 
Nearly ten years later, Koll et al. (39] showed 
that ipsilateral nociceptive "post-delta-flexion" and 
"C-flexion" reflexes were suppressed by analgesic doses 
of morphine (0.3-0.4 mg/kg] in decerebrate, spinal 
cats . 
These studies, while suggestive of an action at 
the spinal level, were somewhat indirect in that motor 
responses, which may not necessarily be related to 
an analgesic effect, were examined. 
In order to study more directly the effects of 
opioids on spinal systems thought to be involved in 
pain, Besson et al. (3] examined the e1ectrophysio1ogica1 
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effects of phenoperidine on dorsal horn lamina V cells 
in spinal cats. Lamina V cells were studied due to 
their apparent importance in the transmission and inte¬ 
gration of nociceptive information. Extrace 1lu1ar 
unitary recordings of cell activity showed that intra¬ 
venous phenoperidine (0.2 mg/kg) markedly reduced both 
spontaneous and evoked activity in the majority of 
cells studied. These effects were reversed by intravenous 
nalorphine. Thus it appeared that phenoperidine had 
a direct effect on cells involved in pain transmission 
at the spinal cord level. It was not clear from this 
study, however, whether this effect was specific to 
1amina V ce11s. 
Kitahata et al. (38) were the first to demonstrate 
such a lamina-specific suppressive effect of morphine. 
Using extrace 1lular recordings in decerebrate, spinal 
cats, they were able to show a dose-dependent suppression 
of spontaneous and evoked activity of cells in laminae 
I and V (associated with nociception) by morphine (0.5- 
2.0 mg/kg i.v.). Activity of cells in laminae IV and 
VI, which respond to non-noxious cutaneous stimuli 
and proprioceptive stimuli, respectively, was unaffected. 
Thus, morphine was shown to have a selective effect 
on cells involved in nociception at the spinal level. 

Lebars et al. (43) found similar results in a 
study looking only at lamina V cells and using a single 
dose (2 mg/kg i.v.) of morphine. They were also able 
to show that the suppressive effects of morphine on 
spontaneous and evoked activity were reversed by naloxone 
or nalorphine, implying a specific, receptor-mediated 
action. 
Calvillo et al. (6) showed that microiontophoretica 11 y 
applied morphine had a depressant effect on dorsal 
horn neurons which responded to noxious radiant heat 
applied to the skin, but had very little effect on 
neurons responding to non-noxious stimuli. This effect 
was reversed by both iontophoretica11y and intravenously 
administered naloxone. 
Other studies also showed a direct spinal action 
of opioids (14,68,69). 
It therefore appeared that opioids were capable 
of exerting a direct effect at the spinal level on 
nociceptive cells. From the above studies, however, 
it was not evident if the observed effects actually 
translated into analgesia in the intact organism. 
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Yaksh and Rudy (78) answered this question and 
went a step further by examining the effects of opioids 
administered directly into the spinal subarachnoid 
space of intact animals. Using rats with a chronically 
implanted catheter in the spinal subarachnoid space, 
they assessed the effects of opioids (fentanyl, morphine, 
codeine, ethylmorphine) on pain thresholds as tested 
by the tail flick response (spinally mediated), and 
the hot plate and squeak-escape responses (both responses 
with a supraspinal component). Small volumes (5 ul) 
of drug injected through the catheter elevated the 
thresholds in all tests in a dose related manner, and 
their effects were reversed by both intraperitoneal 
and intrathecal naloxone. The possibility of rostral 
spread of the injected drug or redistribution to other 
sites via the bloodstream were both effectively excluded. 
In a similar manner, Yaksh (75) showed that small doses 
(40-160 ug) of intrathecal morphine produced behaviorally 
defined analgesia of prolonged duration (greater than 
10 hours with 80 ug) in the cat and monkey. 
RELATIVE SIGNIFICANCE OF SPINAL AND SUPRASPINAL EFFECTS 
Thus, it was shown that opioids, acting directly 
at the spinal cord level, could produce analgesia in 
the intact animal. A question which remained was, 
how much, if any, of the analgesic action of systemically 
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administered opioids was attributable to an effect 
at the spinal level relative to supraspinal sites of 
action? Using a similar preparation as above, Yaksh 
and Rudy (79) found that following intraperitonea 1 
administration of an analgesic dose of morphine, intra¬ 
thecal naloxone (up to 40 ug) was not able to completely 
reverse the analgesic effects. This suggested that 
the morphine was acting upon spinal sites and supraspinal 
sites; the latter site not being accessible to the 
administered naloxone. 
Hanaoka et al. (27), in another study, compared 
the effects of intravenous morphine on the activity 
of lamina V spinal neurons in cats with intact and 
transected spinal cords. They found a greater degree 
of suppression of spontaneous and evoked of 
these cells in cats with intact spinal cords as compared 
to those with the cord transected. They also found, 
however, that intravenous naloxone was able to reverse 
this suppressive effect in cats with transected spinal 
cords, leading them to conclude that there was a direct 
effect at the spinal cord level, which may be modulated 
to some degree by a supraspinal effect. 
It seems, therefore, that for systemically adminis¬ 
tered opioids, effects may be present at both supraspinal 

and spinal sites, giving rise to analgesia in the intact 
animal (as noted above, however, there is still some 
controversy regarding this issue—see 7,8) . 
For the sake of completeness, it should be noted 
that opioids are thought not to affect conduction through 
peripheral nerves—another possible site of action 
(41,77,81). 
SITES OF OPIOID ACTION WITHIN THE SPINAL CORD 
One aspect of spinal opioid analgesia which remains 
to be c1arified--something with which this study is 
concerned — is that of the site of opioid action within 
the spinal cord itself. Attention has focused on the 
dorsal horn, as several lines of evidence point to 
this area as the site of action of spinal opioids. 
Duggan et al. (15) showed that iontophoretic adminis¬ 
tration of morphine into the substantia gelatinosa 
region of the dorsal horn inhibited the discharge of 
WDR neurons in laminae IV and V in response to nociceptive 
stimuli, while responses to innocuous stimuli were unchanged. 
These effects were reversed by naloxone given iontophoreti- 
cally into the substantia gelatinosa or given i 
In contrast to this, when morphine was administered 
in the vicinity of the cell bodies of the neurons, 
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no such inhibitory effect was observed. This suggested 
that opioids were acting upon receptors in the upper 
part of the dorsal horn—namely, the substantia gelatinosa. 
As noted earlier, this is an area where autoradiographic 
studies have demonstrated a relatively high concentration 
of receptors . 
Further evidence that the opioids may be acting 
in the dorsal horn comes from comparing the time course 
of inhibition of lamina V WDR neurons following intrathecal 
morphine with that of the appearance of behaviorally 
defined analgesia after intrathecal morphine. Onset 
of the anti-nociceptive effect of intrathecal morphine 
(80-500 ug) when measured by the thermally evoked skin 
twitch is at around 15 to E 0 minutes in cats (76). 
Similarly, spinally applied morphine (E50 ug) reduces 
the sponatneous and noxiously evoked activity of lamina 
V WDR neurons in decerebrate, spinal cats by approximately 
70% within S5 minutes (3S). Therefore, at a time when 
nociceptive cells in the dorsal horn are inhibited, 
analgesia is present, again suggesting an action in 
the dorsal horn. 
It has also been shown that spinally applied fentanyl 
(E5 ug) will inhibit the noxiously evoked activity 
of dorsal horn WDR neurons by about 70% six minutes 
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after application, as compared to the 25-30 minutes 
required for morphine to achieve the same degree of 
suppression [64]. This faster action of fentanyl may 
coefficient, which be related to its lipid 
has been correlated with the rate at which these drugs 
diffuse into brain tissue (30) . Thus, it has been 
speculated that fentanyl's 1ipophi1icity allows it 
to penetrate relatively quickly to the site of action 
in the dorsal horn, while morphine's poor lipid solubi¬ 
lity hampers its penetration into the dorsal horn, 
delaying the onset of its action. 
Such lines of evidence suggest that the dorsal 
horn is a probable site of action of spinally administered 
opioids. Duggan’s work (above) further implicates 
the substantia gelatinosa region as a possible site 
of action. There are no studies, however, which show 
what the rate and extent of penetration of spinally 
administered opioids into the spinal cord are. For 
example, while iontophoretically applied opioids in 
the substantia gelatinosa may be able to inhibit the 
activity of nociceptive cells, we do not know if these 
drugs, when given spinally, are actually able to reach 
these potential sites of action within an amount of 
time consistent with the electrophysiological studies 
(32,64). The current study hopes to clarify this issue. 
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CLINICAL USE OF SPINALLY ADMINISTERED OPIOIDS 
The potential spinal action of opioids has attracted 
considerable clinical interest. As mentioned above, 
animal studies showed that opioids applied in small 
doses directly to the spinal cord were able to produce 
a behaviorally defined analgesia of long duration. 
In addition, this analgesia was produced without any 
apparent effects on motor, respiratory, or autonomic 
functions of the animal [75). These facts, together 
with the already established techniques for administering 
drugs into the spinal subarachnoid and epidural spaces, 
suggested exciting possibilities for the control of 
pain in clinical settings. It appeared ideal, for 
example, for the control of postoperative pain—pain 
without any motor, respiratory, or autonomic 
Although intrathecal morphine may have been used 
clinically over 80 years ago (<49) , Wang and his colleagues 
(72) in 1979, were the first to report on a double¬ 
blind, controlled study of intrathecal opioids in humans. 
In six out of eight patients suffering from intractable 
pain secondary to cancer, intrathecal morphine (0.5- 
1 .0 mg) produced complete pain relief for 12 to 24 
hours. The remaining two patients reported pain relief 
after morphine and after saline injection, although 
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the relief lasted longer after morphine. The i 
found no evidence of sedation, respiratory depression, 
or impairment of other neurological functions. 
This report was soon fallowed by many other clinical 
studies on intrathecal and epidural administration 
of opioids (see 3),prompting the statement that "never 
in the history of medicine has a concept progressed 
as rapidly from laboratory experimentation with animals 
to clinical application in man...(17)” 
This initial enthusiasm was somewhat tempered 
by reports of various side effects of intrathecal and 
epidural opioids, including pruritis, nausea, vomiting, 
and, most importantly, delayed respiratory depression. 
Nonetheless, clincal studies using spinal opioids 
have become increasingly common. Intrathecal and epidural 
opioids have been shown to be effective in management 
of postoperative and cancer pain, while their 
in controlling the pain of labor remains 
(9,76). Epidural opioids have received considerably 
more attention in these investigations, perhaps in 
part due to the lower incidence of respiratory depression 
with this route of administration (9,26) 
and also to the ease of giving repeated doses. 
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Methods using indwelling catheters for repeated intrathecal 
or epidural administration of opioids and totally implantable 
systems have been used successfully in some cases for 
the treatment of chronic pain states (9,76). 
Thus, epidural and intrathecal opioids hold much 
promise as new methods of managing acute and chronic 
pain. Data from animal and human studies, however, 
are still incomplete. Bromage (4) pointed out early 
on the need for extensive basic and clinical studies 
and cautioned against the widespread use of these techniques 
without due consideration for the side effects produced. 
Despite continuing accumulation of data from basic 
and clinical investigations, it is not yet known which 
drugs in what doses and in what volumes should be used. 
Thus, spinal administration of opioids in humans is 
best considered as still being in an investigational 
stage at this time. As further knowledge on the relevant 
anatomy, physiology, and pharmacology of spinal opioids 
is gained, safe and appropriate use of this technique 





As described above, various methods have been 
employed in attempts to study opiate receptor localization 
and opiate binding, beginning with tissue homogenates 
and proceeding to autoradiographic methods. Autoradiographs 
are based on the principle that ionising radiation from 
ve isotopes in a sample can induce a change 
in silver bromide crystals suspended in the adjacent 
emulsion such that when the crystal is exposed to a 
developing agent, the crystal is converted to metallic 
solution then dissolves out the si1ver. A 
crystals not reduced to metallic silver, leaving a 
pattern of silver grains which reflect the distribution 
of radioactive material in the underlying sample. 
This study uses tritium as the radioactive isotope. 
Tritium decays by emitting B particles (essentially 
electrons of nuclear origin) and has a half life of 
12.3 years. 
The first autoradiograph is said to have been 
made in 1867 (55). Many refinements and modifications 
in the technigue have been made since that time. In 
the case of autoradiographs involving diffusible materials, 
(as in the present study) one technical difficulty is 
encountered in trying to limit diffusion of the 
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particles during the various phases of 
tissue processing. Several technigues have been developed 
in an attempt to create radiographs which reflect the 
true distribution of radioactive molecules (55,56,20). 
Although slight exist in these various 
technigues, most depend on the use of rapidly frozen 
tissue which is allowed to dry at low temperatures 
in low humidity environments. Such technigues were 
used by Atweh and Kuhar (1) in their studies on the 
anatomical distribution of opiate receptors referred 
to above. More recently, Herkenham and Pert (29) described 
a technigue in which tissues were fixed using dry formal¬ 
dehyde vapors prior to processing, resulting in well 
preserved tissue guality without disruption of specific 
opiate binding. 
graphy is felt to be suited for receptor 
and ligand distribution studies as it allows the visuali¬ 
zation of relatively low concentrations of laballed 
drugs and, in addition, allows for localization of 
the drug within intact tissue, rather than homogenates 
or otherwise anatomically disrupted tissues. This 
makes it possible to correlate anatomical/structural 
data with pharmacological and physiological data — something 
this study hopes to do (see below). 
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The autoradiographic technique used in the current 
study attempts to minimize redistribution of the labeled 
molecules during tissue processing. However, compared 
to some more rigorous methods, significant movement 
of labeled drug is thought to occur. The degree of 
such movement, however, is felt to be important only 
if localization is attempted at the cellular level. 
This preliminary study is concerned only with the overall 
distribution of the drug—not specific binding—and 
thus the technique used is felt to be satisfactory. 
As studies requiring detailed localization are performed, 
more rigorous methods will undoubtedly need to be employed. 
AIMS : 
Before proceeding further, it should be noted 
and stressed that the current study is of a preliminary 
nature. Aside from the aims discussed below, one major 
goal is to establish the experimental technique necessary 
for more detailed studies in the future. Thus, it 
is expected that some variations in the methodology 
will occur during the study, and that the initial sets 
of data obtained may not necessarily lead to definitive 
conclusions. 
That notwithstanding, one objective of this study 
is to the nature of penetration of spinally 
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applied morphine into the spinal cord tissue. By applying 
radiolabe1led morphine and obtaining autoradiographs 
of spinal cord tissue at specified time intervals, an 
indication of the depth of penetration and distribution 
of spinally administered morphine in the spinal cord 
is hoped to be obtained. 
Furthermore, the data obtained on the penetration 
of morphine will be compared to existing electrophysio- 
logic data on spinally administered morphine. In 
attempts will be made to relate this study’s finding: 
with those in a study by Homma et al. (32). 
Homma examined the effects of spinally applied 
morphine (0.1 S 0.25 mg) on the activity of dorsal 
horn WDR neurons of decerebrate, spinal cord-transected 
cats. It was found that 0.25 mg of morphine applied 
directly onto the spinal cord was able to suppress 
both spontaneous and noxiously evoked (radiant heat) 
activity of WDR neurons. The data of interest is shown 
in figure 2, which illustrates the time course of suppression 
of the WDR neurons. At 15 minutes, evoked activity 
is suppressed to 48% of control, and at 30 minutes, 
it is suppressed to 30% of control values. In several 
neurons followed for one hour after morphine adminii 
there was no indication of recovery of neuronal 
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These effects were partially reversed by intrathecal 
naloxone and further reversed when intravenous naloxone 
was added. 
In the current study, a relationship between the 
temporal changes in drug localization (as indicated 
by the autoradiographs) and physiological responses 
to the drug (as indicated by Homma's study) will be 
sought. More specifically, an attempt will be made 
to show whether the reduction in WDR activity described 
above depends on the availability of morphine in that 
region, or is independent of it. 
In addition, some indication of the speed of penetra¬ 
tion of morphine into the spinal cord is hoped to be 
obtained. The relatively slow onset of spinal morphine 
analgesia, as noted previously, has been ascribed to 
its low lipophilicity which has been thought to be a 
limiting factor for penetration of the drug to its sites 
of action within the cord matter. Is this in fact the 
case--i.e., can the slow onset of action of spinal morphine 
be explained by slow penetration of the drug? 
This study is not constructed to allow any inferences 
about specific opiate binding. The autoradiographs 
will only show overall distribution of morphine within 
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the cord, and will include specifically and nonspecifically 
bound molecules which will not be distinguishable. 
It is therefore not the intention of the current study 
to define a precise site of action of spinally applied 
morphine within the spinal cord. 
In summary, the objectives of this study are to: 
1. Begin to establish an appropriate autoradiographic 
technique for the study of penetration of opioid 
compounds into the spinal cord for use in future 
studies . 
2. Obtain an indication of the rapidity with which 
morphine penetrates into the spinal cord following 
spinal administration and relate this to the known 
delay in onset of spinal morphine analgesia. 
3. Seek a relationship between temporal changes in 
drug localization and known physiological responses 
of dorsal horn WDB neurons. 

METHODS 
Experiments were conducted using adult cats of 
either sex weighing approximately 3-4 kg. Animals 
were anesthetized with a mixture of halothane, nitrous 
oxide, and oxygen. Cannulations of an external jugular 
vein and a carotid artery were then performed, followed 
by a tracheostomy. The animals were paralyzed with 
pancuronium bromide and respirations were controlled 
by a positive-pressure ventilator. The animal was 
then placed in a stereotaxic frame and decerebrated 
by bilateral electrolytic lesions in the midbrain reti¬ 
cular formation. Anesthesia was then discontinued, 
and ventilation was performed with 100% oxygen. Arterial 
blood pressure, core body temperature, and end-tidal 
CO^ were monitored and maintained within normal limits. 
Laminectomy was then performed at LI through SI and 
the dura was reflected, exposing the spinal cord. 
Warm normal saline was placed onto the cord as necessary 
to prevent it from drying out. 
The morphine solution to be applied was then made, 
3 
using 25 ul of H-morphine (72.7 Ci/mmole, 1 mCi/cc, 
New England Nuclear) and 0.25 mg of morphine sulfate 
in 0.5 cc of normal saline. The resulting solution 
(total volume of 525 ul) was applied directly onto 
the central portion of the exposed cord following gentle 
C3. 
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suctioning of the fluid surrounding the cord. 
Following a time interval of 30 seconds, 5 minutes, 
or 10 minutes, the cord was rapidly dissected out, 
dipped quickly into chilled normal saline, then immersed 
in isopentane cooled to approximate1y -65°C with dry 
ice. After 30 seconds, the frozen cord was removed 
and cut into five sections (numbered 1-5 from rostral 
to caudal) each 2-3mm thick, which were replaced into 
the cooled isopentane. The time reguied for cord removal 
varied slightly, but averaged around 60 seconds. In 
some cases, the solution covering the cord was suctioned 
off immediately before cord removal. 
Individual pieces of the frozen tissue were affixed 
to tissue chucks using an embedding compound (Lipshaw 
M-1) and sectioned using IEC-CTF cryostat (International 
Eguipment Carp.) at -15°C. Section thickness was set 
at 8 u. The tissue sections were picked up onto cold 
standard microscope slides which had been previously 
cleaned and coated with gelatin. Slides were then 
placed into a slide box with dessicant capsules and 
t 




The next step involved dipping of the slides into 
a liquid nuclear emulsion. Under appropriate safelighting 
conditions, slides which had been allowed to warm to 
room temperature under vacuum were dipped vertically 
into a liquid emulsion (Ilford K-5) diluted 1:2 with 
double distilled deionized water which was kept at 
40°C in a water bath. The dipped slides were then 
allowed to drain and dry partially for about 15 minutes 
in a vertical position on a slide rack to ensure a 
consistent thickness of the emulsion over the tissue 
sections. The slides were then transferred to light 
tight slide boxes with dessicant capsules, and stored 
under vacuum in a dessicator at -15°C for exposure. 
Following exposure under those conditions for 
four weeks, the slides were allowed to warm to room 
temperature once again under vacuum in the dessicator 
in preparation for development. Development was carried 
out under appropriate safelighting using Kodak D-19 
developer, Kodak Indicator Stop Bath, and Kodak Fixer. 
Slides were developed for 3 minutes at 20°C, with 1 
minute in the stop bath, 5 minutes in the fixer and 
two rinses in distilled water. 
The developed slides were then stained using a 
2.5% cresyl violet solution. Slides were immersed 
€ 
directly into the cresyl violet after the development 
process for 3-5 minutes then subsequently immersed 
in distilled water, 75% ethanol, 90% ethanol, and 100% 
ethanol for approximately 30 seconds each. 
Autoradiographs prepared in this manner were then 
observed under a microscope (Olympus BH-T). Counting 
of autoradiographic grains was done under direct visua 
2 
by counting within a G25 u area as outlined by a grid 
superimposed upon the tissue image by a camera lucida 
attachment. Sample grain counts were obtained from 
the posterior column area, laminae I, II, V, VII, and 
the ventral horn area (figure 3}. For each area of 
tissue sampled, three separate, randomly selected area 
were counted, and the average of these was taken as 
the grain count for that area. 
For each time interval, tissue was obtained from 
two animals. analyses were carried out 
using the t-test for unpaired data. 
:£~i\ 
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It should be noted that the technique described 
above was arrived at after a variety of problems were 
encountered and several modifications introduced. 
Tissue was initially sectioned at a 16 u thickness, 
but it became evident that thinner sections would 
be required to allow even staining and prevent exten- 
svie overlapping of autoradiographic grains. Emulsion 
thickness was also a problem—attempts to use undiluted 
emulsion led to radiographs with several levels of 
exposed grains superimposed upon each other making 
counting quite difficult. Experiments with several 
different dilutions showed that the 1:2 dilution provided 
a uniform and nearly single layer of grains. One of 
the most crucial aspects in terms of preservation of 
histological quality was the temperature of tissue. 
During the initial studies, slides were often allowed 
to warm to room temperature then replaced into the 
freezer several times prior to final development and 
staining. This often led to wrinkled and cracked tissue 
of poor histological quality. Subsequent experiments 
were carried out in such a manner as to minimize the 
number of times which the tissue was allowed to warm 
to room temperature — in the case of the most recent 
studies, this was reduced to twice: when the slides 
are dipped into emulsion and prior to development. 
This led to a remarkable improvement in histological 
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quality. Modifications continue to be made at this 
time in attempts to improve the consistency and quality 




Using the methods described above, autoradiographs 
of cross sections of the spinal cord were obtained which 
had good histological preservation and uniformly low 
2 
radiographic background [in general 0-2 grains/625 u ]. 
Control slides prepared with "cold" tissue showed no 
evidence of chemographic artifacts. Figure 4 shows 
representative photomicrographs of the exposed, developed 
and stained autoradiographs. 
Tables 1, 2, and 3 show the mean grain counts per 
625 U2 for each of the areas sampled, listed according 
to the '’segment” from which the tissue came, for the 
30 second, 5 minute, and 10 minute intervals, respectively. 
It was initially expected that grain counts would show 
a rostra 1-cauda1 difference in distribution which would 
be evident as differences between counts in segments 
1-5. Inspection of tables 1, 2, and 3, however, does 
not reveal any consistent trend in grain counts by 
segments. 
Thus, data was also pooled without regard to segment 
number, to obtain mean counts of the "total” for each 
area sampled. These results are shown in table 4, 
and graphically represented in figure 5. 
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For laminae V, VII, and the ventral horn, there was 
a statistically significant decrease in the mean grain 
density from 30 seconds to 5 minutes. The remainder 
of the areas showed no significant changes in grain 
density during that interval. From 5 minutes to 10 
minutes, however, all areas showed a significant increase 




One aim of this study was to establish an autoradio¬ 
graphic technique for the study of penetration of opioids 
into the spinal cord. The technique developed in the 
current study appears to be useful for this purpose . 
That is, it was possible, using the technique described 
above, to "follow" the penetration of spinally applied 
morphine into the spinal cord with time. Nonetheless, 
some problems do remain. If these autoradiographs 
were, in fact, representative of the distribution of 
morphine molecules at given moments in time, one might 
expect a relatively clear "front" of activity of the 
penetrating drug. No such clearly demarcated "fronts" 
of activity were seen, however, in any of the tissue 
samples. Also of note is the relatively large variability 
in the grain counts (see tables 1-3). 
These observations suggest the possibility of 
significant movement or diffusion of the morphine during 
processing. Although the technique employed attempted 
to minimize such movement, a few of the steps in processing 
may still be allowing for such movement to take place. 
During sectioning of the tissue on the microtome, the 
tissue will thaw to some extent as it is cut and carried 
across the blade. This thawing together with any ambient 
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moisture may have allowed for some trans1ocation of 
the morphine molecules. It is also possible that, 
after repeated sectioning, the blade itself had become 
contaminated with radiolabelled morphine molecules 
which were then picked up randomly onto tissue sections 
as they passed over the blade. It is unlikely, however, 
that this contributed greatly to variation in grain 
counts. One final step during which movement of radiola- 
belled morphine may have occurred is the dipping of 
slides into emulsion. The moisture and elevated temper¬ 
ature of the emulsion solution contacting the tissue 
may have allowed for some movement of the morphine. 
Regardless of the cause, future modifications 
in technique will need to control movement of drug 
during processing to a greater extent, as more anatomical 
resolution is required. The method described by Herkenham 
and Pert involving partial fixation of tissues prior 
to fixation may be the best way to achieve such control. 
The use of microscope slides pre-dipped in emulsion 
is another possibility, although this introduces the 
significant technical difficulty of manipulating fragile 
tissue sections under dark, safelit conditions. 

Despite this , the results of this 
study show that spinally applied morphine, althouqh 
relatively hydrophilic, is able to penetrate to the 
deeper laminae of the spinal cord within a few minutes 
of application. It can only be said, though, that the 
morphine penetrates to such a degree, and no conclusion 
can be drawn regarding its actions in those areas. 
That is, the results show that morphine penetrates 
relatively rapidly into the spinal cord, but it is not 
clear if the amount which has penetrated is sufficient 
for it to lead to an effect. Clinically, the onset 
of spinal morphine analgesia may reguire 30 minutes 
to 1 hour. Thus, it may be the case that while these 
results suggest relatively rapid penetration of morphine 
into the cord, a longer interval of time must pass 
before sufficient amounts have penetrated deeply enough 
to lead to the onset of analgesia. Proof of this, of 
course, will reguire more precise, guantitative methods 
to be developed and employed. 
It was initially expected that the autoradiographs 
which would advance with time. As already noted, this 
was not found, making correlation with physiological 
data somewhat more than expected. Nonetheless, 
within 30 seconds, morphine was present in levels above 
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background in all the areas sampled. Grain counts 
for all areas sampled also increased significantly 
between 5 and 10 minutes. These results are consistent 
with those of Homma et al. referred to earlier [see 
fig. 2). Within 3 minutes after morphine application, 
evoked activity of dorsal horn WDR neurons had been 
suppressed to about 70% of control. At twelve minutes, 
the activity was suppressed to about 55% on control. 
The increase in grains at ten minutes is consistent 
with this increased suppression. This suggests that 
suppression of lamina V WDR neurons may be dependent 
on the presence of morphine in the lamina V area. 
Again, it should be stressed that this study does not 
imply anything about specific drug-receptor interactions, 
or a precise site of action of morphine. 
In general, there appears to be two possible mechanisms 
by which spinal morphine may lead to suppression of 
lamina V WDR neuron activity and thus, presumably, 
lead to analgesia. One is that morphine acts in the 
area of the substantia gelatinosa on either receptors 
of inhibitory interneurons or of dendrites of depper 
lying lamina V neurons projecting superficially. The 
other possibility is that morphine acts directly on 




The study by Duggan using micro-iontophoresis 
of opioids described above [19) strongly suggests that 
opioids acted within the substantia gelatinosa to produce 
their inhibitory effects on deeper lying nociceptive 
neurons. The relatively rapid penetration of morphine 
into the spinal cord as demonstrated in this study, 
however, suggests that morphine could be acting at 
deeper levels. The results of the present study, while 
still preliminary, imply that the time course of increasing 
grain counts in the superficial and deeper layers of 
the cord is consistent with the time course of WDR 
neuron suppression as shown earlier [32) . Thus, the 
possibility cannot be ruled out, based on this study, 
that spinally applied morphine acts at deeper layers 
of the cord to bring about suppression of WDR neurons 
located in those layers. 
This study examined only three time intervals. 
As more intervals are examined (15, 30 minutes, 1 hour, 
e.g.), better correlation between drug location and 
physiological effect should be able to be made. In 
it would be of interest to examine the 
grain distribution after extended of time 
such as 6, 12, or 24 hours. At these non- 
specifically bound molecules may have diffused away 
leaving only specifically bound molecules. Furthermore, 
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Future studies should examine the penetration character¬ 
istics of more lipophilic drugs such as fentanyl, which 
are assumed to act more quickly due to their rapid 
penetration into the spinal cord. 
One result which is difficult to explain in this 
study is that of the significant decrease in grain 
density in laminae V, VII, and the ventral horn area 
between 30 seconds and 5 minutes. There is no apparent 
satisfactory explanation for this finding, except to 
attribute it to chance variation, despite 
significance. 
Finally, one possible criticism of the study design 
might concern the conditions under which the morphine 
was applied. These conditions were somewhat "unnatural" 
in that the spinal cord was exposed for a considerable 
length along which the dura and its vessels were reflected 
or removed. Needless to say this is somewhat different 
from the conditions under which the drug is administered 
clinically. The penetration characteristics of morphine 
may be quite different when an intact dura is present 
together with a circulating pool of CSF. Thus, it 
may be useful to design studies in which the drug is 
administered through a needle puncture in an otherwise 





1. The present study has tested a technique of autoradio¬ 
graphy as a method of studying penetration of opioid 
drugs into the spinal cord, and found this technique 
to be satisfactory, although it is concluded that 
further refinements/modifications will be necessary. 
2. Despite its hydrophilic nature, spinally applied 
morphine was shown to penetrate to the deeper laminae 
of the spinal cord within minutes. No definitive 
conclusions can be drawn, however, concerning the 
action of the drug at these layers. 
3. Temporal changes in the density of autoradiographic 
grains was found to be consistent with the initial 
time course of physiological responses to spinal 
morphine. Again, no inferences can be made about 
specific opiate binding or action. 
4. Future studies should include experiments with 
longer time intervals after morphine application, 
modifications in the autoradiographic technique 
to minimize movement of the drug molecules, use 
of other more lipid soluble opioid compounds, and, 
finally, an experimental design more closely paralleling 




Schematic representation of conditions used by Goldstein (see text). 
Solid symbols represent radioactive levorphanol while open symbols 
indicate a 100-fold excess of nonradioactive compounds: dextrorphan in 




FIGURE 2. __ 
~“rse of suppression of dorsal horn WDR neuronal evoked 
following 0.25 mg of spinal morphine in cats. C - control, 





Representation of areas in which sample grain counts were performed. 
Each dot represents an area in which grains were counted. 
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FIGURE 5 . 
Mean number of grains per 625 u ^ for each time interval. Data derived 
from aggregate of values without regard to segment for each time. 
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